Poseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyPoseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler
4M ago
Poseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition
Premium
Market News
Poseida Therapeutics (NASDAQ:PSTX) Stock Skyrockets on News of Roche Holdings Acquisition
4M ago
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
Premium
The Fly
Trump threatens tariffs, Zoom reports Q3 beat: Morning Buzz
4M ago
Poseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR
PremiumThe FlyPoseida Therapeutics to be acquired by Roche for $9.00 per share plus CVR
4M ago
Poseida Therapeutics Advances in Cell Therapy Innovations
Premium
Company Announcements
Poseida Therapeutics Advances in Cell Therapy Innovations
5M ago
Poseida Therapeutics holds virtual R&D Day
Premium
The Fly
Poseida Therapeutics holds virtual R&D Day
5M ago
Poseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1
PremiumThe FlyPoseida Therapeutics reports data from Phase 1 trial of P-BCMA-ALLO1
6M ago
Poseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1
Premium
The Fly
Poseida Therapeutics says FDA grants RMAT designation to P-BCMA-ALLO1
7M ago
Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial
Premium
The Fly
Poseida Therapeutics initiates P-BCMA-ALLO1 Phase 1b trial
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100